Text Size:

In This Section

Guidelines and Forms

Vaccine Consent Form - Any vaccine (for adults incapable of consenting for self) July 9, 2010 [PDF, 257 KB]
Vaccine consent form for any vaccine - for adults incapable of consenting for themselves.

Biologicals Return and Redistribution Requirements Form December 4, 2009 [PDF, 41 KB]
Note: A Field Return Form must be submitted to the biologicals desk first. The desk will then contact you to advise on the completion of this form.

PHSA Labs ILI Outbreak Lab Form October 7, 2009 [PDF, 100 KB]
Influenza Like Illness (ILI) Outbreak Laboratory Form: Specimen Collection and Shipping. Facilities experiencing outbreaks should submit specimens using the "6-packs". Before shipping the specimens, the “ILI Outbreak Laboratory Form” should be FAXED, with all patients' names clearly written, to the PHSA Laboratory Services at 604-707-2675. The Influenza Like Illness (ILI) Outbreak Laboratory Form should also be included with the specimens when they are shipped.

PHSA Labs Sample Container Order Form October 7, 2009 [PDF, 69 KB]
BC health providers: use this form to order specimen containers from PHSA Laboratories.

PHSA Labs Virology Requisition Form October 7, 2009 [PDF, 649 KB]
In BC, this form must accompany specimens for virus culture by PHSA Laboratories.

Vaccine Temperature Form October 7, 2009 [PDF, 260 KB]
Temperature log form for tracking vaccine refrigerator temperature twice daily.

BC Swine Influenza (A/H1N1) Case Report Form June 30, 2009 [DOC, 93 KB]
BCCDC-updated version of PHAC swine flu CRF. Last updated June 30, 2009.

Reference Materials for Immunizers February 8, 2010 [HTML]
Contains links to things such as the Immunization Manual, the Immunization Communications Tool, consent forms, MSP codes for physcians, and the BCCDC Immunization Forum (audio and presentations).

Influenza 2009-10: Seasonal and Pandemic Vaccine Q&A for Immunizers November 6, 2009 [PDF, 159 KB]
Q&A resource for immunizers covering common questions on the seasonal and H1N1 influenza vaccines.

Training H1N1 Vaccine Slideshow for Immunizers November 6, 2009 [PDF, 768 KB]
Powerpoint slideshow for training on the H1N1 influenza vaccine.

Immunization Competency Program Overview October 5, 2009 [PDF, 130 KB]
An overview of the competencies, learning objectives, and resources covered by the BCCDC Immunization Competency Program.

Immunization Competencies for BC Health Professionals September 18, 2009 [PDF, 124 KB]
The competencies contained in this document range from knowledge of the scientific basis of immunization to essential immunization practices and contextual issues relevant to immunization. Each competency is supported by a number of guiding learning objectives and key terms.

BC Pandemic Influenza Preparedness Plan June 9, 2009 [PDF, 2 MB]
British Columbia Pandemic Influenza Preparedness Plan: Guidelines for Planning, Response and Recovery. Version 3, last updated August 2005.

Communicable Disease Control Manual May 29, 2009 [HTML]
BC Communicable Disease Manual.

BC Harm Reduction Strategies and Services Policy and Guidelines May 7, 2009 [PDF, 45 KB]
These guidelines support harm reduction strategies and services pertaining to problematic substance use and sexual health.

BCCDC Interim Options for Clinicians Considering Influenza Antivirals in the Context of Changing Patterns of Resistance, 2008-09 Season March 5, 2009 [PDF, 125 KB]
These interim guidelines dated March 5, 2009 are based on evolving knowledge and up-to-date surveillance data for the 2008-09 influenza season which indicate a high rate of oseltamivir resistance in A/H1N1 viruses and a continued high rate of amantadine resistance in A/H3N2 viruses. Health care providers considering the use of antivirals should consult surveillance updates to stay informed about influenza activity and antiviral resistance patterns in their area. The appropriate choice of antiviral options may change. Influenza antivirals should be used selectively and judiciously for appropriate clinical indications. Product monographs and other references should be consulted for detailed prescribing information.

NOTE: Documents referenced on this page require Adobe Reader.